The 41 patients were divided into experimental and control groups, both groups were treated with Western combined therapy, on that basis, The experimental group were administered Coronary heart Shutong capsules, three at a time and three times a day, observing the main symptoms, signs and ECG, blood flow changes and so on before treatment and after 6 month’s treatment.

Objective: To investigate the protective effect and mechanism of Coronary heart Shutong capsule on arrhythmia in rats.

OBJECTIVE:To establish the quality standard for Shuguan tongmai capsule(STC).

Determination of danshensu in GuanXintong capsules by HPLC;

Content determination of Danshensu in Guanxintong capsules by HPLC;

Protective effects of Xinnao Shutong capsule on acute cerebral ischemic injury of multiple infarcts in rats;

Effect of Xinnao Shutong Capsule on Cardiac Muscle Cell Apoptosis and Protein Expressions of Bcl-2 and Bax in Hyperlipidemia Rats after Myocardial Infarction;

Effect of Xinnao Shutong capsule on apoptosis after cerebral ischemia and reperfusion in rats;

Effect of Xinnaoshutong capsule on monoamine neurotransmitter in Cortex in rats with cerebral ischemia and reperfusion;

Effect of Xinnaoshutong capsule on IL-1β、TNF-α and neurocyte apoptosis in cerebral ischemia and reperfusion rats;

Objective To survey effectiveness of CHD treated by Xinnaoshutong capsule and salvia miltiorrhiza tablets.

HPLC determination of hydroxysafflor yellow A and geniposide in Shuxin Tongnao capsules